APLS
Apellis·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
APLS Filings
Filing Date
Form Description
Form Type
2025-11-18
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-18 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-17
Form 144 - Report of proposed sale of securities
Ownership
2025-11-17 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-30
Apellis Pharmaceuticals, Inc. (APLS) Q3 2025 Earnings Call Transcript
Earnings Call
2025-10-30 · Earnings Call
Apellis Pharmaceuticals, Inc. (APLS) Q3 2025 Earnings Call Transcript
2025-10-30
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-10-30 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-23
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-23 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-21
Form 144 - Report of proposed sale of securities
Ownership
2025-10-21 · Ownership
Form 144 - Report of proposed sale of securities
2025-10-17
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-10-17 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-10-16
Form 144 - Report of proposed sale of securities
Ownership
2025-10-16 · Ownership
Form 144 - Report of proposed sale of securities
